GPBAR1 and Alzheimer disease: Taurodeoxycholic acid (TDCA) inhibits P2X7 receptor (P2X7R)-mediated NLRP3 inflammasome activation in keratinocytes and innate immune cells as a GPCR19 agonist (24), which play a crucial role in AD pathogenesis.